# FDA recall D-0025-2026

> **STAQ Pharma, Inc.** · Class III · drug recall initiated 2025-10-09.

## Product

FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date

## Distribution

Nationwide in the U.S.

## Key facts

- **Recall number:** D-0025-2026
- **Recalling firm:** STAQ Pharma, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-10-09
- **Report date:** 2025-10-22

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Denver, CO, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0025-2026

## Citation

> AI Analytics. FDA recall D-0025-2026. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/D-0025-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*